Successful treatment of hepatitis C in sickle-cell disease [10]

Annals of Internal Medicine

Volumn 133, Issue 9, 2000, Pages 750-751

  Swaim, M W ^a   Agarwal, S ^a   Rosse, W F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HYDROXYUREA; RECOMBINANT ALPHA2A INTERFERON; RIBAVIRIN;

ADULT; CASE REPORT; CAUSE OF DEATH; FEMALE; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; LIVER BIOPSY; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

EID: 0034619477     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-9-200011070-00033     Document Type: Letter

References (5)

1. Hepatitis C in sickle cell anemia
2. Epidemiology of hepatitis C
3. Liver transplantation in a patient with sickle cell anemia
4. Mortality in sickle cell disease. Life expectancy and risk factors for early death
5. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia